|13th August 2020||Ted William Karkus||50,000||Open or private sale||$2.75||$137,500.00|
|13th August 2020||Louis Md Gleckel||50,000||Open or private purchase||$2.75||$137,500.00|
|9th July 2020||Ted William Karkus||54,150||Bona fide gift||$0.00|
|9th July 2020||Ted William Karkus||28,600||Bona fide gift||$0.00|
|9th July 2020||Ted William Karkus||25,550||Bona fide gift||$0.00|
|1st July 2020||Louis Md Gleckel||7,878||Grant/award etc.||$1.43||$11,265.54|
|1st July 2020||Jason Michael Barr||4,727||Grant/award etc.||$1.43||$6,759.61|
|1st April 2020||Jason Michael Barr||3,641||Grant/award etc.||$1.85||$6,735.85|
|1st April 2020||Louis Md Gleckel||6,068||Grant/award etc.||$1.85||$11,225.80|
|26th March 2020||Ted William Karkus||100,000||Open or private sale||$1.75||$175,000.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer consumer healthcare products. Its products include TK supplement. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989.